Community invests in MIA's new trial
19 July 2016
The community has responded generously to the recent appeal by Melanoma Institute Australia to fund a specialised nursing position in an exciting new clinical trial.
More than $240,000 was raised during our recent tax appeal. Funds will be used to cover the costs of a Clinical Nurse Consultant for three years for our Match Mel trial - a trial that will offer hope to patients who have exhausted all other avenues for treatment.
“My warmest thanks to our community of supporters for contributing so generously to our recent appeal," says MIA's CEO Carole Renouf. "It’s fantastic to have hit the target because this is all about hiring for a pivotal role to care for patients in a new trial. It’s impossible to hire if you don’t have secure funding, and this type of specialised nursing position is one research grants will not cover.”
This unique clinical trial will use existing drugs to target rare genes in melanoma patients. They will not have to wait years for drug development as these therapies are already available and in use for other cancers.
However, because these drugs have not been used specifically in the melanoma setting before, close monitoring and support by a Clinical Nurse Consultant is required for patients. In this trial setting, having someone to coordinate patient care who is accessible 24/7 and understands treatments, how they work, and how to manage their physical and psychological side-effects is key for an advanced melanoma patient.
We also appreciate Emma Betts for sharing her story for our appeal and her outstanding fundraising efforts towards the appeal.
The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research.
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'